Milk preservation

download Milk preservation

of 4

Transcript of Milk preservation

  • 7/29/2019 Milk preservation

    1/4

    JOINT FAO/WHO ACTIVITIES CONTRIBUTING TO THE PROVISION OF SCIENTIFIC

    ADVICE TO CODEX (CCFH)

    June 2005

    Call for Data and Expertise

    The Lactoperoxidase System of Raw Milk Preservation

    Background

    The Lactoperoxidase System of Raw Milk Preservation is currently the only approved method of rawmilk preservation, apart from refrigeration, in Codex. It was adopted by Codex Alimentarius as aguideline in 1991 (CAC GL 13/91) following an evaluation by JECFA

    1. The Lactoperoxidase System

    (LP-system) operates by the reactivation of the enzyme lactoperoxidase, which is naturally present inraw milk, by the addition of thiocyanate and a source of peroxide. This results in a blocking of

    bacterial metabolism thereby preventing the multiplication of bacteria present in the milk. The effectcan therefore be described as bacteriostatic but the effect has a limited duration which is determined

    by temperature.

    The system is promoted by FAO as an effective means of extending the shelf life of raw milk indeveloping countries where technical, economical and/or practical reasons do not allow the use of

    cooling facilities for maintaining the quality of raw milk. Use of the LP-system in areas which

    currently lack an adequate infrastructure for collection of liquid milk, would ensure the production ofmilk as a safe and wholesome food, which otherwise would be virtually impossible.

    2

    The LP-system has been evaluated by JECFA, who concluded that when used according to the draft3

    guidelines, the LP-system does not present a toxicological hazard4. The bacteriostatic effect of the

    system means that it neither improves nor disguises poor quality milk.

    Since 1997, FAO has noted a number of requests for clarification from its Member Countries

    regarding the limitation on the use of milk treated by the LP-system, or its derived dairy products,intended for international trade. Countries are concerned and confused that although the LP-system is

    recognised as safe for use in raw milk for human consumption, it is not approved for use in milk ormilk products intended for the international market. This confusion is based on a footnote in the first

    edition of the FAO/WHO Food Standards Series, Vol. 12, on Milk and Milk products. The issue ofusing LP-system treated milk in international trade has been raised in various Codex committee

    meetings including those on Food Hygiene and Milk and Milk Products by both Member Countries

    and the Global Lactoperoxidase Programme Secretariat based at the FAO Headquarters, Rome, Italy.

    Most recently the issue was brought to the attention of the 27th

    Session of the Codex AlimentariusCommission in July 2004 as a concern from the 36

    thSession of the Codex Committee on Food

    Hygiene (CCFH) regarding theDraft Code of Practice for Milk and Milk Products in which the LP-

    system was listed as a biostatic. The Commission agreed to add the following text to the end of

    1Joint FAO/WHO Expert Committee on Food Additives

    2Guidelines for the preservation of raw milk by use of the lactoperoxidase system (CAC/GL 13-1991)

    (http://www.codexalimentarius.net/download/standards/29/CXG_013e.pdf)3

    Subsequently adopted as the current guidelines, footnote 2.4Evaluation of certain food additives and contaminants (Thirty-fifth report of the Joint FAO/WHO Expert

    Committee on Food Additives). WHO Technical Report Series, No. 789, 1990, and corrigenda. [1989, TRS 789-

    JECFA 35] (http://jecfa.ilsi.org/annex1.htm)

  • 7/29/2019 Milk preservation

    2/4

    footnote 9 of Appendix II of the draft Code: The use of the lactoperoxidase system for milk and milk

    products in international trade will be re-examined by the Committee on Food Hygiene (CCFH) aftercompletion of an expert review by FAO and WHO of available data and considering the FAO

    Lactoperoxidase Expert Group report on the benefits and potential risks of LP-system. CCFH will thenreview the issue in 2006.

    In order to respond to Member Country concerns and to provide scientific advice to the next session of

    the CCFH in 2006, FAO and WHO are planning to hold a Technical Meeting on the benefits and any

    possible risks associated with the LP-system for raw milk preservation and any milk products derivedfrom the system. The Technical Meeting will be held in Rome in late 2005.

    The objective of the Technical Meeting will be to determine the benefits (economic and nutritional)

    and the level of health risks, if any, posed by the application of the LP-system and advise on the safetyof LP-system treated milk and derived milk products.

    Request for Data

    FAO/WHO requests governments, interested organizations, milk producer groups / organisations /

    institutions, milk collecting individuals or groups, processors, academia, and individuals to submit any

    available data relevant to the specific areas indicated above. This data may be either published orunpublished. Reference should be made to related published studies, where applicable. The receipt of

    such information is important in ensuring the provision of appropriate science-based expert advice onthe use of the LP-system for raw milk preservation (and products derived from such preserved milk)at the international level.

    Please submit any relevant information (electronic and/or hard copies) in any official United Nationslanguage (English, French, Spanish, Arabic, Chinese or Russian), and with the title and short summary

    in English, by 31 August 2005 to the address given at the end.

    Information Required

    The available peer reviewed literature regarding the benefits (economic and nutritional) and possiblehealth risks associated with the use of the LP-system for the preservation of raw milk (and any derived

    milk products) from multiple species (bovine, buffalo, ovine, caprine and camelids) is limited.

    Additional information is therefore needed from all geographic regions to determine the extent towhich the LP-system is used, its benefits and any associated health and/or economic risks or

    technological constraints.

    Although health concerns do not currently appear to be an issue associated with the use of the LP-system, this has been determined largely by a review of information published prior to 1989

    undertaken by the Global Lactoperoxidase Programme. It is, therefore, critical to review any more

    recent information relevant to either positive or negative health effects that may be linked to the use ofthe LP-system in raw milk and milk products of multiple species.

    The key data requirements are as follows:

    1. Microbiological data. The LP-system is known to have an overall bacteriostatic effect(predominantly inhibitory) and a bactericidal effect against some gram negative bacteria i.e.,

    Pseudomonas and E. coli. Data is therefore sought on the effects and performance of the LP-systemon:

    the microbial load of milk of various species; milk of differing microbial quality and under different conditions such as ambient

    temperatures.

  • 7/29/2019 Milk preservation

    3/4

    2. Economic value and trade data. The use of the LP-system may have economic and trade impacts

    and implications and data is requested regarding:

    estimations or evidence of increased volumes of milk collected and processed and/or reducedlosses and wastage due to the use of the LP-system;

    estimations or evidence of how the LP-system has stimulated milk production and contributedto increased value along the dairy value chain (milk producers groups/ organisations/institutions, milk collector and processors are likely sources of this information); and

    estimations or evidence of any potential trade losses due to the existing restriction oninternational trade of LP-system treated milk or milk products.3. Human health and nutrition data. Milk is an important component of the daily diet in manydeveloping countries and it is essential that it remains a healthy and nutritious product. Recentinformation is requested on:

    post 1989 toxicological data on the LP-system and/or its constituent components, as forexample it has been recognized that the thiocyanate ion can interfere with iodine uptake;

    availability of safer milk {lower microbial load} and increased access to nutritious milk ormilk products related to the use of the LP-system; and

    recorded human health risks (acute or chronic) associated with either the short or long-termexposure to LP-system treated milk or its derived milk products (such as reduced iodine

    metabolism) either in general or to the more vulnerable sectors of society e.g. children, HIV-AIDS affected households etc.

    4. Data on processing / technological issues. Various technologies, products and processes areinvolved in the use of the LP-system, and data is required on:

    the current availability and use of technologies and processes for preserving raw milk with theLP-system;

    any effect of the LP-system on the further processing of raw milk and its relationship with therecognised time-temperature limitations on the activity of the system;

    the benefits, or otherwise, of the LP-system as compared to other methods of milkpreservation; and

    whether or not the LP-system has resulted in either an increase or decrease of other nonapproved methods of milk preservation such as addition of hydrogen peroxide, neutralisers

    etc.

    5. Any other relevant information.

    IMPORTANT: When providing data, please provide detailed information regarding the source,

    sampling techniques, methodology and quality control procedures (for laboratory analysis) used plusany relevant organizational and institutional context to the data.

    Confidentiality and unpublished data.

    FAO and WHO recognise that some information and relevant data which are required may be

    unpublished and/or of a confidential nature. With regard to unpublished information, this remains theproperty of the owner of the original material and can be used for subsequent publication. Unpublished

    confidential studies that are submitted will be safeguarded, in so far as it is possible withoutcompromising the work of FAO and WHO. Specific issues relating to confidentiality should be

    discussed directly between the information owners and FAO/WHO. For these and other issues pleasecontact FAO at the contact provided below.

  • 7/29/2019 Milk preservation

    4/4

    Request for Experts

    To meet the objectives of the Technical Meeting FAO/WHO are also seeking suitably qualifiedexperts in the following areas: public health, milk chemistry and hygiene, food safety economics,

    toxicology, microbiology, application of the LP-system (particularly in countries in Africa, Asia,Central and South America, the Caribbean and the Near East) and the dairy industry. Full curriculumvitae (including list of publications) of potential and interested experts should to be sent by the 31

    August to the address given below.

    Contact Details

    All correspondence and emails should be addressed to:

    Ms Irene Hoffmann

    Chief, Animal Production ServiceAnimal Production and Health Division

    Food and Agriculture Organization of the United Nations

    Viale delle Terme di Caracalla00100 Rome, Italy

    Telephone: + 39 06 5705 2796Facsimile: + 39 06 5705 5749

    Email: [email protected]

    The subject of any emails should be Re: Call for LP-system data and experts.

    ________________________________